Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Lubberding AF, Veedfald S, Achter JS, Nissen SD, Soattin L, Sorrentino A, et al
Doctors will check: Blood sugar levels, usually every few months, to track how well diabetes is controlled Kidney function, especially in people with diabetes or those who may be at risk for dehydration Weight and blood pressure, to monitor progress and overall health Eye exams, especially for people with diabetes, to watch for any changes in vision Signs of pancreatitis, gallbladder problems, or allergic reactions, especially if new symptoms appear People taking other diabetes medicines may need extra monitoring for low blood sugar
Image Credit: azimmytws / Shutterstock.com A recent BMJ study determines whether the use of glucagon-like peptide-1 (GLP-1) receptor agonists by type 2 diabetes (T2D) patients increases the risk of self-harm, suicidal ideation, and suicide as compared to patients prescribed dipeptidyl peptidase-4 (DPP-4) or sodium-glucose cotransporter-2 (SGLT-2) inhibitors
PCO-02/NCT02637284 oral PK
US$ 22.15
US$ 28.89
US$ 21.22
US$ 29.56
US$ 22.46
US$ 22.12
US$ 29.04
US$ 27.43
US$ 21.30
US$ 26.56
US$ 27.70
US$ 26.38
US$ 22.43
